Analyst firms · Morgan Stanley · GRFS
Morgan Stanley GRFS price target and rating history
Grifols S.A. (GRFS) · Health Care
Morgan Stanley rates Grifols S.A. (GRFS) Overweight, as of its latest action on Feb 12, 2025. It has published 4 rating actions on GRFS since April 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- Not stated
- Median target, all firms
- Too few
- Actions on GRFS
- 4
Every Morgan Stanley rating on GRFS
- Feb 12, 2025
- Apr 12, 2023
- Mar 3, 2023
- Apr 8, 2022
Questions about Morgan Stanley and GRFS
- What is Morgan Stanley's rating on GRFS?
- Morgan Stanley rates GRFS Overweight, a bullish rating, as of Feb 12, 2025.
- When did Morgan Stanley last change its view on GRFS?
- On Feb 12, 2025, Morgan Stanley resumes coverage at Overweight.
All Morgan Stanley ratingsGRFS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.